Prediction of myocardial viability: Tl-201 versus sestamibi versus teboroxime compared with FDG uptake

Clinical Nuclear Medicine

Volumn 23, Issue 7, 1998, Pages 432-436

  Kiser, Jackson W ^a   Drane, Walter E ^a   Mastin, Susan T ^a   Nicole, Michael W ^a  

^a UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

Author keywords

F 18 Fluorodeoxyglucose; Hibernating Myocardium; Myocardial Viability; TC 99m Sestamibi; Tl 201 Thallium Chloride

Indexed keywords

FLUORODEOXYGLUCOSE F 18; METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M; TEBOROXIME TC 99M; THALLIUM CHLORIDE TL 201;

ADULT; ARTICLE; CELL VIABILITY; CLINICAL PROTOCOL; FEMALE; HEART MUSCLE BLOOD FLOW; HEART MUSCLE ISCHEMIA; HEART MUSCLE METABOLISM; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; ORAL DRUG ADMINISTRATION; ORAL GLUCOSE TOLERANCE TEST; PREDICTION; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;

CORONARY CIRCULATION; FEMALE; FLUORODEOXYGLUCOSE F18; FORECASTING; HEART; HEART TRANSPLANTATION; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL ISCHEMIA; MYOCARDIAL REPERFUSION; MYOCARDIAL STUNNING; MYOCARDIUM; ORGANOTECHNETIUM COMPOUNDS; OXIMES; RADIOPHARMACEUTICALS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; TECHNETIUM TC 99M SESTAMIBI; THALLIUM RADIOISOTOPES; TISSUE SURVIVAL;

EID: 0031683965     PISSN: 03639762     EISSN: None     Source Type: Journal    
DOI: 10.1097/00003072-199807000-00007     Document Type: Article

References (22)

1. Burt RW, Perkins OW, Oppenheimer BE, et al: Direct comparison of fluorine-18-FDG SPECT, fluorine-18-FDG PET and rest thallium-201 SPECT for detection of myocardial viability. J Nucl Med 36:176, 1995.
2. Soufer R, Dey HM, Ng CK, Zaret BL: Comparison of sestamibi single-photon emission computed tomography with positron emission tomography for estimating left ventricular myocardial viability. Am J Cardiol 75:1214, 1995.
3. Schwaiger M, Hicks R: The clinical role of metabolic imaging of the heart by positron emission tomography. J Nucl Med 32:565, 1991.
4. de Silva R, Yamamto Y, Rhodes CG, et al: Preoperative prediction of the outcome of coronary revascularization using positron emission tomography. Circulation 86:1738, 1992.
5. Ferman S: Clinical applications of myocardial substrate utilization with positron emission tomography. Mol Cell Biochem 88:S70, 1989.
6. Drane WE, Abbott FD, Nicole MW, Mastin ST, Kuperus JH: Technology for FDG SPECT with a relatively inexpensive gamma camera. Work in progress. Radiology. 191:461, 1994.
7. Gibson RS, Watson DD, Taylor GJ, et al: Prospective assessment of regional myocardial perfusion before and after coronary revascularization surgery by quantitative thallium-201 scintigraphy. J Am Coll Cardiol 1f:804, 1983.
8. Sawada SG, Allman KC, Muzik O, et al: Positron emission tomography detects evidence of viability in rest technetium-99m sestamibi defects. Am Coll Cardiol 23:92, 1994.
9. Marshall RC, Leidholdt EM Jr, Znang D-Y, Barnett CA: Technetium-99m hexakis 2-methoxy-2-isobutyl isonitrile and thallium-201 extraction, washout, and retention at varying coronary flow rates in rabbit heart. Circulation 82:998, 1990.
10. Bisi G, Sciagrà R, Santoro GM, Rossi V, Fazzini PF: Technetium-99m-sestamibi imaging with nitrate infusion to detect viable hibernating myocardium and predict postrevascularization recovery. J Nucl Med 36:1994, 1995.
11. Maurea S, Cuocolo A, Soricelli A, et al: Enhanced detection of viable myocardium by technetium-99m-MIBI imaging after nitrate administration in chronic coronary artery disease. J Nucl Med 36:1945, 1995.
12. Maurea S, Cuocolo A, Soricelli A, et al: Myocardial viability, index in chronic coronary artery disease: Technetium-99m-methoxyisobutyl isonitrile redistribution. J Nucl Med 36:1953, 1995.
13. Pace L, Cuocolo A, Marzullo P, et al: Reverse redistribution in resting thallium-201 myocardial scintigraphy in chronic coronary artery disease: An index of myocardial viability. J Nucl Med 36:1968, 1995.
14. Dilsizian V, Arrighi JA, Diodati JG, et al: Myocardial viability in patients with chronic coronary artery disease: Comparison of 99mTc-sestamibi with thallium reinjection and fluorine-18-fluoro-deoxy-glucose. Circulation 89:578, 1994.
15. Tamaki N, Ohtani H, Yamashita K, et al: Metabolic activity in the areas of new fill-in after thallium-201 reinjection: Comparison with positron emission tomography using fluorine-18-deoxyglucose. J Nucl Med 32:673, 1991.
16. Blood DK, McCarthy DM, Sciacca RR, Cannon PJ: Comparison of single-dose and double-dose thallium-201 myocardial perfusion scintigraphy for the detection of coronary artery disease and prior myocardial infarction. Circulation 58:577, 1978.
17. Ritchie JL, Albro PC, Caldwell JH, Trobaugh GB, Hamilton GW: Thallium-201 myocardial imaging: A comparison of the redistribution and rest images. J Nucl Med 20:477, 1979.
18. Leppo JA, Meerdink DJ: Comparative myocardial extraction of two technetium-labelled BATO derivatives (SQ30217, SQ32014) and thallium. J Nucl Med 31:64, 1990.
19. Stewart RE, Schwaiger M, Hutchins GD, et al: Myocardial clearance kinetics of technetium-99m-SQ30217: A marker of regional myocardial blood flow. J Nucl Med 31:1183, 1990.
20. Maublant JC, Moins N, Gauchon P, Renoux M, Zhang Z, Veyre A: Uptake of technetium-99m-teboroxime in cultured cells: Comparison with thallium-201 and technetium-99m-sestamibi. J Nucl Med 34:255, 1993.
21. Ohtake T, Yokoyama I, Watanabe T, et al: Myocardial glucose metabolism in noninsulin-dependent diabetes mellitus patients evaluated by FDG-PET. J Nucl Med 36:456, 1995.
22. Brunken R, Tillisch J, Schwaiger M, et al: Regional perfusion, glucose metabolism, and wall motion in patients with chronic electrocardiogram Q-wave infarctions: Evidence for persistence of viable tissue in some infarct regions by positron emission tomography. Circulation 73:951, 1986.